SLA 0.00% $3.34 silk laser australia limited

wait before topping up, page-43

  1. 52 Posts.
    You must be getting RSI from all the mouse clicking you're doing putting people on ignore and off again. Howzabout choosing one and sticking to it champ.
    Nothing wrong with internet sales to make money, just aren't going to support a trillion dollar company, let alone a 1 billion dollar company. Only way to riches here is widespread medical adoption and this just isn't going to happen until Solascam do some phase II and III trials and be upfront about their results - maybe even publish them in a peer-reviewed journal or two - English language preferred of course. A real, real worry that they haven’t a clear clinical trial program to do robust trial that could potentially demonstrate efficacy for at least one of the myriad of applications they claim BioAlphabets are promoted for. Most doctors in the Western world aren’t going to touch this stuff until they do trials just like all other biotechs and pharmaceutical companies do to meet regulatory approval needs in Western Europe and North America. Backdoor approvals in markets like Russia aren’t going to cut it.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.